ATHA
USDAthira Pharma Inc. Common Stock
$4.280+0.130 (3.133%)
Real-time Price
Healthcare
Biotechnology
United States
Price Chart
Loading Chart...
Key Metrics
Market Metrics
Open
$4.150
High
$4.498
Low
$4.150
Volume
0.03M
Company Fundamentals
Market Cap
16.9M
Industry
Biotechnology
Country
United States
Trading Stats
Avg Volume
0.03M
Exchange
NCM
Currency
USD
52-Week Range
Low $2.2Current $4.280High $8.26
Related News
GlobeNewswire
Athira Pharma Announces Reverse Stock Split
BOTHELL, Wash., Sept. 11, 2025 (GLOBE NEWSWIRE) -- Athira Pharma, Inc. ("Athira" or "Company") (NASDAQ:ATHA), a clinical stage biopharmaceutical company focused on developing small molecules to restore neuronal health
View more
Related Stocks
NCNA
NuCana plc American Depositary Share
NASDAQ
Biotechnology: ...
ABVEW
Above Food Ingredients Inc. Warrants
NASDAQ
Packaged Foods
SGHT
Sight Sciences Inc.
NASDAQ
Medical/Dental ...
LGND
Ligand Pharmaceuticals Incorporated
NASDAQ
Biotechnology: ...
ZIONO
Zions Bancorporation N.A. Dep Shs Repstg 1/40th Perp Pfd Ser G
NASDAQ
Major Banks
Stay Updated
Set price alerts, get AI analysis updates and real-time market news.